DrugScreens.com spotlights SAFElife toxicology tests for workplaces

By AI, Created 11:12 AM UTC, May 20, 2026, /AGP/ – DrugScreens.com named SAFElife its featured brand for May, highlighting CLIA-waived urine cups, dip cards and oral fluid kits for employers and other B2B buyers. The lineup is aimed at faster workplace screening with fentanyl and EtG detection options for some products.

Why it matters: - DrugScreens.com is leaning into workplace drug screening demand with a product line built for employers, staffing firms and clinical programs across the continental United States. - The SAFElife lineup adds options for faster collection and broader detection, including fentanyl and EtG in some urine products. - The mix of CLIA-waived and Forensic Use Only products gives organizations more flexibility as they manage different testing environments.

What happened: - DrugScreens.com announced SAFElife drug test products as its featured brand for May. - The spotlight covers CLIA-waived urine cups, CLIA-waived dip cards, Forensic Use Only urine cups, and saliva drug screen collection kits. - DrugScreens.com said the featured month reflects continued demand from B2B customers for fast, reliable workplace and clinical screening products.

The details: - The SAFElife urine cup lineup includes CLIA-waived cups and FUO cups with fentanyl and EtG detection. - DrugScreens.com said many standard panels historically did not include fentanyl and EtG. - CLIA-waived status allows the cups to be used in non-laboratory settings without added regulatory burden at the testing site. - The SAFElife dip cards are also CLIA-waived and are positioned as a flexible testing format. - SAFElife saliva kits come in FUO and Employment & Insurance classifications. - DrugScreens.com said the saliva kits do not include fentanyl detection. - The company said that distinction helps buyers choose products aligned with their program requirements. - The SAFElife urine cups include tamper-resistant features for high-volume or unmonitored collection settings. - Fast result times are intended to reduce delays during onboarding, post-incident testing and other workplace screening scenarios. - DrugScreens.com does not provide testing or laboratory services directly. - The company supplies products organizations use to run their own testing programs. - DrugScreens.com serves employers, staffing agencies, clinical programs and safety-sensitive industries across the continental United States. - The company offers multiple testing brands and product categories, including urine cups, dip cards and oral fluid collection kits.

Between the lines: - The product mix suggests DrugScreens.com is targeting buyers that want one supplier for both workplace screening and legal or investigative use cases. - Offering FUO and E&I saliva products through the same channel can simplify procurement for organizations that operate multiple screening protocols. - The feature-month framing also signals a sales and marketing push around products that emphasize speed, compliance fit and broader detection coverage.

What’s next: - DrugScreens.com will continue highlighting SAFElife during May. - The company is directing buyers to DrugScreens.com and its social channels for more information. - DrugScreens.com said it will keep matching tests to use cases based on speed, compliance requirements and budget.

The bottom line: - DrugScreens.com is using SAFElife to pitch a more flexible workplace testing lineup, with CLIA-waived and FUO options designed to fit different collection settings and screening needs.